EMEA-EFPIA Info Day discusses drug agency performance, new pediatric regulation and IMI

The European Medicines Agency (EMEA) hosted an information day at its London, UK, offices, in conjunction with the Brussels, Belgium-based European Federation of Pharmaceutical Industries and Associations on February 5.

The one-day event assembled representatives from the EMEA, the drug industry and a select media presence. The general areas covered by the conference were: analysis of the performance indicators for both organizations in 2006 for Initial Marketing Authorization Applications and for type II Variation Applications (Extension of Indications); a review of the first year's experience of new drug legislation (Conditional Marketing Authorizations and Risk Management Plans); implementation of the new pediatric medicines regulation; and the Innovative Medicines Initiative.